Verastem Inc (NASDAQ:VSTM)
| 9.44 BATS BZX Real-Time Price As of 12:09pm ET |  -0.21 / -2.18%Today’s Change | 3.47 Today|||52-Week Range 15.18 | +95.45% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $244.9M |
Company Description
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
Contact Information
Verastem, Inc. 117 Kendrick Street Needham Massachusetts 02494 |
Employees
Shareholders
| Other institutional | 30.10% |
| Mutual fund holders | 13.88% |
| Individual stakeholders | 0.93% |
Top Executives
| Dan Paterson | President, Chief Executive Officer & Director |
| Daniel Calkins | VP, Chief Financial & Accounting Officer |
| Jonathan Pachter | Chief Scientific Officer |
| Louis J. Denis | Chief Medical Officer |
| Hagop Youssoufian | Head-Medical Strategy |
